PURE Bioscience (OTCMKTS:PURE) Sees Large Growth in Short Interest

PURE Bioscience (OTCMKTS:PURE) saw a large increase in short interest in August. As of August 15th, there was short interest totaling 10,100 shares, anincreaseof42.3% from the July 31st total of 7,100 shares. Based on an average daily volume of 60,200 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 60,200 shares, the short-interest ratio is currently 0.2 days.

PURE Bioscience Trading Down 4.9%

OTCMKTS:PURE opened at $0.08 on Tuesday. PURE Bioscience has a twelve month low of $0.05 and a twelve month high of $0.21. The company has a 50-day moving average of $0.08 and a 200-day moving average of $0.08. The firm has a market cap of $9.12 million, a price-to-earnings ratio of -2.04 and a beta of 0.36.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings data on Monday, June 16th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.49 million for the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.